News
13d
Zacks Investment Research on MSNInvestors Heavily Search Docusign Inc. (DOCU): Here is What You Need to KnowDocuSign (DOCU) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
StockStory.org on MSN18d
DocuSign’s Q1 Earnings Call: Our Top 5 Analyst QuestionsDocuSign’s first quarter results surpassed Wall Street’s revenue and profit expectations, yet the market reacted negatively due to concerns around billings growth and the timing of early renewals.
5d
Zacks.com on MSNDocuSign (DOCU) Stock Sinks As Market Gains: What You Should KnowIn the closing of the recent trading day, DocuSign (DOCU) stood at $80.33, denoting a -1.33% move from the preceding trading day.
An uninspiring quarterly earnings report and a clutch of analyst price target cuts put Docusign (NASDAQ: DOCU) stock in the market's doghouse in June. Before the first trading week of the month ...
DocuSign, Inc. DOCU reported impressive first-quarter fiscal 2026 results, wherein earnings per share (EPS) and revenues surpassed the Zacks Consensus Estimate. However, the better-than-expected ...
Finally, Wedbush decreased their price objective on Docusign from $100.00 to $85.00 and set a “neutral” rating on the stock in a report on Thursday, June 12th.
Shares of Docusign stock opened at $76.21 on Tuesday. The firm has a market cap of $15.40 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 27.45 and a beta of 1.08.
SAN FRANCISCO, May 16, 2024 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced that its first quarter fiscal 2025 results will be released on Thursday, June 6, 2024, after the close of the ...
DocuSign Q1 results (DocuSign Q1 earnings deck) DocuSign's revenue grew 7.6% y/y to $763.7 million, beating Wall Street's much more conservative $749.0 million (+5.6% y/y) expectations by a two ...
Docusign's stock trades at 61 times forward earnings and 5 times this year's sales. Confluent can't be valued by its profits, but it trades at 7 times this year's sales.
Docusign, Inc. DOCU has been under considerable selling pressure, with the stock declining 15.4% year to date. This drop is in stark contrast to the 14% rally in its industry and the 6% gain in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results